Links to articles in the current and previous 2 issues of this bulletin are displayed below.
To receive email notifications about new issues of this bulletin, please email: richard.fallis@healthcarelibrary.qub.ac.uk
Are we there yet? CAR-T therapy in multiple myeloma
Blood coagulation factor IX: structural insights impacting hemophilia B therapy
Cell salvage for the management of postpartum haemorrhage (new Cochrane review)
Chimeric antigen receptor T-cell therapy for haematological malignancies
Clinical features, pathophysiology, and management of acute myelopathy following CAR T-cell therapy
Coagulation factor VIII: biological basis of emerging hemophilia A therapies
Dialysis for chronic kidney failure: a review
DLBCL: who is high risk and how should treatment be optimized?
Effect and safety of intravenous iron compared to oral iron for treatment of iron deficiency anaemia in pregnancy (new Cochrane review)
See also: The power and perils of large language models in haematology
Haemodiafiltration versus haemodialysis for kidney failure
The high-grade B-cell lymphomas: double hit and more
Paediatric relapsed acute leukaemia: curative intent chemotherapy improves quality of life
Peripheral T-cell lymphoma: are all patients high risk?
Perspectives on drug development in chronic myelomonocytic leukemia: changing the paradigm
Platelet generation in vivo and in vitro
Primary large B-cell lymphomas of immune-privileged sites
RNA-loaded nanoparticles for the treatment of hematological cancers
Sequencing of therapy for patients with diffuse large B-cell lymphoma in the era of novel drugs
T-cell lymphomas in recipients of CAR-T cells: assessing risks and causalities
Therapeutic strategies targeting aberrant RNA splicing in myeloid malignancies
Treatment for women with postpartum iron deficiency anaemia (updated Cochrane review)
Advanced Drug Delivery Reviews (Nov); Blood (Nov-Dec); BMJ Supportive and Palliative Care (Nov); British Journal of Haematology (Nov-Dec); Cochrane Library (Dec); JAMA (Nov); Lancet, The (Nov)
Advanced imaging for earlier diagnosis and morbidity prevention in multiple myeloma
Blood biomarkers to detect Alzheimer disease in primary care and secondary care
Changes in Alzheimer disease blood biomarkers and associations with incident all-cause dementia
Cryoglobulinemia — one name for two diseases
Current and upcoming treatment approaches to common subtypes of PTCL (PTCL, NOS; ALCL; and TFHs)
Hairy-cell leukemia (NEJM review)
Hope for motherhood: pregnancy after allogeneic hematopoietic cell transplantation
How do we manage hyperhemolysis syndrome?
How I treat acute venous thromboembolism in patients with brain tumors
The impact of hematology electronic consultations on the management of iron deficiency
The intestinal microbiota and cellular therapy: implications for impact and mechanisms
New insights into the biology of T-cell lymphomas
Novel functions for von Willebrand factor
A practical approach to the modern diagnosis and classification of T- and NK-cell lymphomas
Revisiting the full blood count: circulating blood cells and their role in coagulation
Blood (12th Sep-31st Oct); British Journal of Haematology (Oct); European Journal of Haematology (Nov); JAMA (Oct); NEJM (Oct); Transfusion (Oct); Transfusion Medicine (Oct)
CAR T cells vs bispecific antibody as third- or later-line large B-cell lymphoma therapy
Chronic lymphocytic leukaemia (Lancet seminar review)
Cord blood banking: experts raise concern over claims made for stem cell applications
Current challenges in conditioning regimens for MDS transplantation
Dismantling relapsed/refractory mantle cell lymphoma
Elevating fetal hemoglobin: recently discovered regulators and mechanisms
Evaluating minimal residual disease as an intermediate clinical end point for multiple myeloma
The global blood donation index: an imperfect measure of transfusion need
Gut microbiome composition and dysbiosis in immune thrombocytopenia: a review of literature
Hemoglobin Bart’s hydrops fetalis: charting the past and envisioning the future
Hot under the clot: venous thrombogenesis is an inflammatory process
Household water lead and hematologic toxic effects in chronic kidney disease
How I diagnose and treat organizing pneumonia in hematopoietic cell transplant recipients
How I treat bleeding in hereditary hemorrhagic telangiectasia
IL-1 in aging and pathologies of hematopoietic stem cells
Immune thrombocytopenia: pathophysiology and impacts of Romiplostim treatment
Iron, hemochromatosis genotypes, and risk of infections
Momelotinib for the treatment of myelofibrosis
A moonlighting job for α-globin in blood vessels
New frameworks for hematopoiesis derived from single-cell genomics
Novel therapeutic approaches in thalassemias, sickle cell disease, and other red cell disorders
Procoagulant platelets promote immune evasion in triple-negative breast cancer
Blood (11th July-5th Sep); Blood Reviews (Sep); BMJ, The (Jul); JAMA Internal Medicine (Jul); Lancet, The (Aug-Sep)
The Healthcare Library cannot guarantee the correctness or completeness of the information in these bulletins. The information is subject to change and we cannot guarantee it will remain up-to-date. It is your responsibility to check the accuracy and validity of the information. These bulletins are the property of the Healthcare Library; please credit us if re-using or distributing content from them.